AI assistant
Sending…
RESMED INC — Director's Dealing 2021
Feb 17, 2021
30071_dirs_2021-02-17_b3ea4caf-bc2f-48be-a19a-8ff918e37c1e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-02-16
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-16 | ResMed Common Stock | S | 998 | $200.46 | Disposed | 212452 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 16701.2125 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29